Form 4: Prestige Consumer Healthcare Director John F. Kelly Receives Restricted Stock Units
SEC Form 4 Filing
Director John F. Kelly of Prestige Consumer Healthcare Inc. received restricted stock units on August 5th and 6th, 2024, according to a Form 4 filing.
Summary
- John F. Kelly, a director at Prestige Consumer Healthcare Inc., received restricted stock units on August 5 and August 6, 2024.
- On August 5, 2024, he received 555 restricted stock units, which vest on August 5, 2025.
- These units were valued at $37,500, based on a closing stock price of $67.58 on August 5, 2024.
- On August 6, 2024, Kelly received 2,202 restricted stock units as part of the director compensation program.
- These units were valued at $150,000, based on a closing stock price of $68.13 on August 6, 2024.
- These restricted stock units vest on the first anniversary of the grant and will be settled by delivering one share of common stock for each vested unit upon death, separation, or a change in control.
Sentiment
Score: 7
Explanation: The document is a routine disclosure of director compensation, which is generally neutral to positive as it aligns director interests with shareholders.
Future Outlook
The restricted stock units will vest and be settled in the future, contingent on the terms outlined in the filing.
Industry Context
This filing reflects standard practice for compensating board members with equity, aligning their interests with those of shareholders.
Comparison to Industry Standards
- Director compensation packages often include a mix of cash and equity.
- Companies like Church & Dwight and Helen of Troy also use restricted stock units as part of their director compensation.
- The vesting schedules and terms are generally consistent with industry norms, aiming to retain board members and incentivize long-term value creation.
Stakeholder Impact
- Shareholders may view this as a positive sign, as it aligns the director's interests with the company's long-term performance.
- The director benefits from the equity grant, incentivizing their contributions to the company's success.
Key Dates
| Date | Description |
|---|---|
| 08/05/2024 | Reporting Person received 555 restricted stock units. |
| 08/05/2025 | Restricted stock units received on August 5, 2024 vest. |
| 08/06/2024 | Reporting Person received 2,202 restricted stock units. |
| 08/07/2024 | Signature date of the Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.